SCHEMBL738628

SCHEMBL738628

[CH2]C(=O)c1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004766 0.80 NPC1 (0.52)
SCHEMBL1324 0.80 NPC1 (0.62)
Hydrogen Sulfide SCHEMBL28438010 0.78 NPC1 (0.60)
SCHEMBL28449908 0.78 NPC1 (0.60)
Hydrochloric Acid SCHEMBL3543004 0.78 NPC1 (0.60)
SCHEMBL10952701 0.78 NPC1 (0.60)
Bromide SCHEMBL7371333 0.78 NPC1 (0.60)
Ammonia Solution, Strong SCHEMBL16266978 0.78 NPC1 (0.60)
SCHEMBL1491811 0.78
SCHEMBL41312 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230372309-A1 ALPHA-2 ADRENERGIC RECEPTOR ANTAGONIST KYOTO UNIVERSITY (JP) 2023-11-23 US claimed
EP-4218818-A1 ALPHA-2 ADRENERGIC RECEPTOR ANTAGONIST Kyoto University (JP) 2023-08-02 EP claimed
WO-2023106897-A1 NOVEL PEPTIDE DERIVATIVE DERIVED FROM ADIPONECTIN AND USE THEREOF 서울대학교병원 2023-06-15 WO claimed
US-20210024659-A1 NOVEL REACTIVE ALGINIC ACID DERIVATIVES MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2021-01-28 US claimed
US-10011589-B2 Treatments for gastrointestinal conditions BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2018-07-03 US claimed
US-20170073332-A1 Treatments for Gastrointestinal Conditions ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 2017-03-16 US claimed
EP-3116499-A1 TREATMENTS FOR GASTROINTESTINAL CONDITIONS Board of Regents, The University of Texas System (US) 2017-01-18 EP claimed
WO-2015138753-A1 TREATMENTS FOR GASTROINTESTINAL CONDITIONS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-09-17 WO claimed
US-RE43802-E1 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE LLC (US) 2012-11-13 US claimed
EP-2176238-B1 MORPHOLINO PYRIMIDINE DERIVATIVES USED IN DISEASES LINKED TO MTOR KINASE AND/OR PI3K ASTRAZENECA AB (SE) 2012-04-18 EP claimed
WO-1995006030-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1995-03-02 WO claimed
WO-1994025072-A1 RAPAMYCIN CONJUGATES AND ANTIBODIES AMERICAN HOME PRODUCTS CORPORATION (US) 1994-11-10 WO claimed
WO-1994004540-A1 27-HYDROXYRAPAMYCIN AND DERIVATIVES THEREOF AMERICAN HOME PRODUCTS CORPORATION (US) 1994-03-03 WO claimed
US-5256790-A Antibiotic AMERICAN HOME PRODUCTS CORPORATION (US) 1993-10-26 US claimed
EP-0549727-A1 CARBOXYLIC ACID ESTERS OF RAPAMYCIN AMERICAN HOME PRODUCTS CORPORATION (US) 1993-07-07 EP claimed
US-5130307-A Antibody inhibitors; treating organ graft rejection, fungal infections; antiinflammatory agents AMERICAN HOME PRODUCTS CORPORATION (US) 1992-07-14 US claimed
WO-1992005179-A1 CARBOXYLIC ACID ESTERS OF RAPAMYCIN AMERICAN HOME PRODUCTS CORPORATION (US) 1992-04-02 WO claimed
EP-0171251-B1 QUINONE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1990-06-27 EP claimed
US-4725584-A Peptidyl-1-amino-2,4-diols ABBOTT LABORATORIES (US) 1988-02-16 US claimed
US-4725583-A ANTIHYPERTENSIVE ABBOTT LABORATORIES (US) 1988-02-16 US claimed